Monica Forbes
Corporate Officer/Principal at APOGEE THERAPEUTICS, INC.
Net worth: 33 626 $ as of 30/05/2024
Monica Forbes active positions
Companies | Position | Start | End |
---|---|---|---|
APOGEE THERAPEUTICS, INC. | Corporate Officer/Principal | 30/04/2023 | - |
Career history of Monica Forbes
Former positions of Monica Forbes
Companies | Position | Start | End |
---|---|---|---|
CARISMA THERAPEUTICS, INC. | Director of Finance/CFO | 31/07/2019 | 06/03/2023 |
Treasurer | - | 06/03/2023 | |
Nalpropion Pharmaceuticals, Inc.
Nalpropion Pharmaceuticals, Inc. Managed Health CareHealth Services Nalpropion Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the treatment of weight loss. Its products include CONTRAVE, analtrexone HCl & bupropion HCl extended release and Mysimba, a naltrexone HCl/ bupropion HCl prolonged release. The company is headquartered in Morristown, NJ. | Director of Finance/CFO | 30/06/2018 | 31/03/2019 |
OREXIGEN THERAPEUTICS, INC. | Director of Finance/CFO | 23/02/2018 | 26/07/2018 |
Corporate Officer/Principal | 30/09/2014 | 23/02/2018 |
Training of Monica Forbes
San Diego State University | Undergraduate Degree |
Statistics
International
United States | 6 |
Operational
Director of Finance/CFO | 3 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 2 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
APOGEE THERAPEUTICS, INC. | Health Technology |
Private companies | 3 |
---|---|
Orexigen Therapeutics, Inc.
Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
Sesen Bio, Inc.
Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Nalpropion Pharmaceuticals, Inc.
Nalpropion Pharmaceuticals, Inc. Managed Health CareHealth Services Nalpropion Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the treatment of weight loss. Its products include CONTRAVE, analtrexone HCl & bupropion HCl extended release and Mysimba, a naltrexone HCl/ bupropion HCl prolonged release. The company is headquartered in Morristown, NJ. | Health Services |
- Stock Market
- Insiders
- Monica Forbes
- Experience